pubmed: "future oncol"[jour]

NCBI: db=pubmed; Term="Future Oncol"[jour]

Latest articles

Trastuzumab emtansine: a game changer in HER2-positive early breast cancer.

Related Articles Trastuzumab emtansine: a game changer in HER2-positive early breast cancer. Future Oncol. 2020 Jul 31;: Authors: S Mano M Abstract Trastuzumab emtansine (T-DM1), given postoperatively for 14 cycles to patients with human epidermal growth factor receptor 2-positive (HER2-positive)...

Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.

Related Articles Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design. Future Oncol. 2020 Jul 29;: Authors: Khushalani NI, Diab A, Ascierto PA, Larkin J, Sandhu S, Sznol M, Koon HB, Jarkowski A, Zhou M, Statkevich P, Geese WJ, Long GV Abstract...

The relationship between methionine synthase rs1805087 polymorphism and hematological cancers risk.

Related Articles The relationship between methionine synthase rs1805087 polymorphism and hematological cancers risk. Future Oncol. 2020 Jul 29;: Authors: Bai Y, Drokow EK, Waqas Ahmed HA, Song J, Akpabla GS, Kumah MA, Agyekum EB, Neku EA, Sun K Abstract Background: The relationship between hematological...

Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression.

Related Articles Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression. Future Oncol. 2020 Jul 27;: Authors: Germetaki T, Nicholls C, Adams RA, Braun M, Rogan J, Moghadam S, Lenfert E, Lukas A, Edelstein DL, Jones FS, Saunders MP Abstract ...

Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic.

Related Articles Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol. 2020 Jul 27;: Authors: Elghazawy H, Bakkach J, Zaghloul MS, Abusanad A, Hussein MM, Alorabi M, Eldin NB, Helal T, Zaghloul TM, Venkatesulu BP, Elghazaly H, Al-Sukhun...

Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment.

Related Articles Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment. Future Oncol. 2020 Jul 26;: Authors: Abdul Rahman SF, Xiang Lian BS, Mohana-Kumaran N Abstract The B-cell lymphoma 2 (BCL-2) anti-apoptotic proteins have become attractive therapeutic targets...

Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy.

Related Articles Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy. Future Oncol. 2020 Jul 26;: Authors: Teh J, O'Connor E, O'Brien J, Lim WM, Taylor M, Heriot A, Ramsay R, Lawrentschuk N Abstract Penile squamous cell carcinoma (SCC) is...

Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumor.

Related Articles Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumor. Future Oncol. 2020 Jul 23;: Authors: Gelderblom H, de Sande MV Abstract Pexidartinib is an orally administered small molecule tyrosine kinase inhibitor. Phase III ENLIVEN study results...

Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma.

Related Articles Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma. Future Oncol. 2020 Jul 21;: Authors: Jacob A, Shook J, Hutson TE Abstract The VHL mutation-HIF upregulation-VEGF transcription sequence is...

The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.

The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer. Future Oncol. 2020 Jul 20;: Authors: Wang J, Lin H, Zhou M, Xiang Q, Deng Y, Luo L, Liu Y, Zhu Z, Zhao Z Abstract Aim: To construct a survival prediction signature for prostate cancer (PC) based on the RNA N6-methyladenosine...

Discover, share and read the best on the web

Subscribe to RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters! Get unfiltered news feeds or filter them to your liking.

Get Inoreader
Inoreader - Subscribe to RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters!